Completed PHASE4 INTERVENTIONAL 2-arm NCT05903014

Effectiveness of N-Acetylcysteine (NAC) in Motivational Enhancement Therapy for Nicotine Addiction

Effectiveness of N-Acetylcysteine in Motivational Enhancement Therapy for Nicotine Addiction: Study on the Dopaminergic Pathways, Changes in Functional Connectivity of fMRI Bold, and Changes in Smoking Abstinence

Sponsor: Indonesia University

Conditions Nicotine Addiction Nicotine Dependence

Interventions Motivational Enhancement Therapy n-acetylcysteine

Updated 4 times since 2023 Last updated: Oct 1, 2024 Started: Jan 1, 2023 Primary completion: Sep 30, 2023 Completion: Dec 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Nicotine Addiction and Nicotine Dependence, this trial is completed. The trial is conducted by Indonesia University and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Nov 2024 — Present [monthly]

Completed PHASE4

Status: Recruiting → Completed
Sep 2024 — Nov 2024 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jul 2023 — Jul 2024 [monthly]

Recruiting PHASE4

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indonesia University

Data source: Indonesia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia